Albemarle (ALB) enters a pivotal week as Q4 results on Feb 11, 2026, and an earnings call on Feb 12 will test lofty expectations. Recent sharp price swings, elevated valuation, and consensus targets (including a $221M adjusted EBITDA hurdle) set the stage for outsized stock reactions tied to lithium pricing and cash flow metrics.
